Epirubicin and the risk of leukemia: not substantiated? International Collaborative Cancer Group Steering Committee.
Marty
M
M
D015251:Epirubicin / Q000009:adverse effects*; D006801:Humans; D007938:Leukemia / Q000139:chemically induced*; D016609:Neoplasms, Second Primary / Q000139:chemically induced*
D015251:Epirubicin